SRC and cancer: Src is commonly hyper-activated in human cancers and promotes metastasis in part by inducing tumour angiogenesis via a signal transducer and activator of transcription 3 (Stat3)/vascular endothelial growth factor (VEGF)-A signaling pathway [13].